HIV pre-exposure prophylaxis (PrEP)--a quantitative ethics appraisal.

<h4>Background</h4>There is now strong evidence that preventive oral antiretroviral therapy can moderately reduce likelihood of HIV infection. This concept is called HIV pre-exposure prophylaxis (PrEP). Premature closures of some previous PrEP clinical trials, secondary to ethical concer...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Madzouka B Kokolo, Dean A Fergusson, D William Cameron
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2011
Materias:
R
Q
Acceso en línea:https://doaj.org/article/dc74887e0452484db3ba5dc2c059eec3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:dc74887e0452484db3ba5dc2c059eec3
record_format dspace
spelling oai:doaj.org-article:dc74887e0452484db3ba5dc2c059eec32021-11-18T06:48:34ZHIV pre-exposure prophylaxis (PrEP)--a quantitative ethics appraisal.1932-620310.1371/journal.pone.0022497https://doaj.org/article/dc74887e0452484db3ba5dc2c059eec32011-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21850229/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>There is now strong evidence that preventive oral antiretroviral therapy can moderately reduce likelihood of HIV infection. This concept is called HIV pre-exposure prophylaxis (PrEP). Premature closures of some previous PrEP clinical trials, secondary to ethical concerns, did not stop research. We aimed to appraise the extent of ethics considerations reporting in PrEP study documents.<h4>Methods</h4>We conducted a systematic quantitative ethics appraisal, grounded in PrEP literature and using eight principles proposed by Ezechiel Emanuel. We developed an a priori checklist of 101 evidence-based ethics items. We obtained protocols for eleven of nineteen clinical controlled studies identified. Two reviewers independently appraised study documents against the checklist. Ethics appraisal was synthesized using adjusted percentages of items reported.<h4>Results</h4>On average, 58% of the 101 ethics items were mentioned or addressed in documents, with variations noted both across studies and across principles. Considerations pertaining to social value were least reported (43% of checklist items, on average) whereas considerations related to informed consent and favorable risk-benefit ratio were most reported (75% of checklist items, on average).<h4>Discussion</h4>Some PrEP studies reportedly address more ethics considerations than others but, overall, ethics considerations reporting could be much improved. While this review does not allow us to comment on the actual execution of HIV PrEP trials, it is a reminder that optimism generated by potentially effective interventions should not overshadow the importance of ethics in research design and development. Improving ethics reporting might improve the perceived value of PrEP research and subsequent data.Madzouka B KokoloDean A FergussonD William CameronPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 6, Iss 8, p e22497 (2011)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Madzouka B Kokolo
Dean A Fergusson
D William Cameron
HIV pre-exposure prophylaxis (PrEP)--a quantitative ethics appraisal.
description <h4>Background</h4>There is now strong evidence that preventive oral antiretroviral therapy can moderately reduce likelihood of HIV infection. This concept is called HIV pre-exposure prophylaxis (PrEP). Premature closures of some previous PrEP clinical trials, secondary to ethical concerns, did not stop research. We aimed to appraise the extent of ethics considerations reporting in PrEP study documents.<h4>Methods</h4>We conducted a systematic quantitative ethics appraisal, grounded in PrEP literature and using eight principles proposed by Ezechiel Emanuel. We developed an a priori checklist of 101 evidence-based ethics items. We obtained protocols for eleven of nineteen clinical controlled studies identified. Two reviewers independently appraised study documents against the checklist. Ethics appraisal was synthesized using adjusted percentages of items reported.<h4>Results</h4>On average, 58% of the 101 ethics items were mentioned or addressed in documents, with variations noted both across studies and across principles. Considerations pertaining to social value were least reported (43% of checklist items, on average) whereas considerations related to informed consent and favorable risk-benefit ratio were most reported (75% of checklist items, on average).<h4>Discussion</h4>Some PrEP studies reportedly address more ethics considerations than others but, overall, ethics considerations reporting could be much improved. While this review does not allow us to comment on the actual execution of HIV PrEP trials, it is a reminder that optimism generated by potentially effective interventions should not overshadow the importance of ethics in research design and development. Improving ethics reporting might improve the perceived value of PrEP research and subsequent data.
format article
author Madzouka B Kokolo
Dean A Fergusson
D William Cameron
author_facet Madzouka B Kokolo
Dean A Fergusson
D William Cameron
author_sort Madzouka B Kokolo
title HIV pre-exposure prophylaxis (PrEP)--a quantitative ethics appraisal.
title_short HIV pre-exposure prophylaxis (PrEP)--a quantitative ethics appraisal.
title_full HIV pre-exposure prophylaxis (PrEP)--a quantitative ethics appraisal.
title_fullStr HIV pre-exposure prophylaxis (PrEP)--a quantitative ethics appraisal.
title_full_unstemmed HIV pre-exposure prophylaxis (PrEP)--a quantitative ethics appraisal.
title_sort hiv pre-exposure prophylaxis (prep)--a quantitative ethics appraisal.
publisher Public Library of Science (PLoS)
publishDate 2011
url https://doaj.org/article/dc74887e0452484db3ba5dc2c059eec3
work_keys_str_mv AT madzoukabkokolo hivpreexposureprophylaxisprepaquantitativeethicsappraisal
AT deanafergusson hivpreexposureprophylaxisprepaquantitativeethicsappraisal
AT dwilliamcameron hivpreexposureprophylaxisprepaquantitativeethicsappraisal
_version_ 1718424384441417728